36 is the current PE of CSL ( biggest biotech on asx ) , and just happens to be same PE for reoccurring royalties for Nuren. Asx bio startup ( like botanix ) that recieved fda clearance recently.
It could just be a fluke they are both 36, but what a coincidence. I only looked at those two. CSL for what investors value a long term solid , slow growth medical vs short term startup ( Nuren ) with first product just in market, so 36 PE is what the evidence points towards in my opinion.
The big unknown, is the E ?
Currently priced at around 3000 patients for 1 year, or 36,000 patients for a 1 off 1 month buy.
- Forums
- ASX - By Stock
- BOT
- Where will we be in 12 months time?
Where will we be in 12 months time?, page-137
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
38.0¢ | 39.0¢ | 37.5¢ | $2.216M | 5.782M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 178007 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 285564 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 178007 | 0.375 |
8 | 282494 | 0.370 |
8 | 314910 | 0.365 |
11 | 1117151 | 0.360 |
10 | 554977 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 285564 | 4 |
0.390 | 773569 | 22 |
0.395 | 528735 | 13 |
0.400 | 1443101 | 33 |
0.405 | 765060 | 15 |
Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
BOT (ASX) Chart |